Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

PCOS significantly affects women's mental health, and more research is needed to develop effective treatments for these issues.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Licorice has health benefits but can also cause side effects, so it should be used carefully.

Traditional Indian remedies are used for hair health, but more scientific evidence is needed to prove their safety and effectiveness.

Autoimmune markers may help diagnose and manage PCOS.

New methods may speed up drug development for male subfertility.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Women with PCOS often have acne, obesity, and excess hair, especially on the chin and upper lip.

Polycystic Ovarian Syndrome (PCOS) can be effectively treated with Ayurvedic dietary management.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

The interdigital gland of Vembur sheep shows sex-based differences in size and chemical makeup, possibly affecting communication and disease protection.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.